Digital assessment of endothelial function and ischemic heart disease in women.

[1]  R. Rubinshtein,et al.  Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. , 2010, European heart journal.

[2]  Carl J Pepine,et al.  Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. , 2009, Archives of internal medicine.

[3]  Ramachandran S Vasan,et al.  Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study , 2008, Circulation.

[4]  V. Vaccarino,et al.  Coronary Heart Disease in Women: Update 2008 , 2008, Clinical pharmacology and therapeutics.

[5]  R. Campisi.  Noninvasive assessment of coronary microvascular function in women at risk for ischaemic heart disease , 2007, International journal of clinical practice.

[6]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[7]  R. Sacco,et al.  The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. , 2007, Atherosclerosis.

[8]  N. Cook,et al.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.

[9]  K. Zou,et al.  Receiver-Operating Characteristic Analysis for Evaluating Diagnostic Tests and Predictive Models , 2007, Circulation.

[10]  C Noel Bairey Merz,et al.  Angina with "normal" coronary arteries. , 2005 .

[11]  Amir Lerman,et al.  Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. , 2004, Journal of the American College of Cardiology.

[12]  L. Shaw,et al.  Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease: Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[13]  J. Keaney,et al.  The clinical implications of endothelial dysfunction. , 2003, Journal of the American College of Cardiology.

[14]  Ayan R Patel,et al.  Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. , 2003, American heart journal.

[15]  Amir Lerman,et al.  Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. , 2003, Journal of the American College of Cardiology.

[16]  A. Quyyumi,et al.  Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.

[17]  M. Hijmering,et al.  Variability of flow mediated dilation: consequences for clinical application. , 2001, Atherosclerosis.

[18]  N. Reichek,et al.  Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. , 2000, The New England journal of medicine.

[19]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[20]  S. Reis,et al.  Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. , 1999, Journal of the American College of Cardiology.

[21]  N Reichek,et al.  The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. , 1999, Journal of the American College of Cardiology.

[22]  A. Takeshita,et al.  Angina pectoris caused by coronary microvascular spasm , 1998, The Lancet.

[23]  K. Kugiyama,et al.  Coronary spasm: clinical features and pathogenesis. , 1997, Internal medicine.

[24]  K. Kugiyama,et al.  Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. , 1997, Journal of the American College of Cardiology.

[25]  K. Kugiyama,et al.  Role of adenosine in pathogenesis of syndrome X: assessment with coronary hemodynamic measurements and thallium-201 myocardial single-photon emission computed tomography. , 1996, Journal of the American College of Cardiology.

[26]  H. Drexler,et al.  Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.

[27]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[28]  K. Kugiyama,et al.  Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. , 1986, Circulation.

[29]  Paul M. Ridker,et al.  Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women , 2007 .

[30]  H. Ishizaka,et al.  Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. , 1996, Journal of the American College of Cardiology.